Weimin Li
Impact in
- Geriatrics and Gerontology top 5%
- Frailty in Older Adults
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Pleural and Pulmonary Diseases 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Lung Cancer Diagnosis and Treatment 3
- Oncology 12
- Inflammatory Biomarkers in Disease Prognosis 10
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Yanjiao Shen (1 shared paper)Lingling Tan (1 shared paper)Ming Yang (1 shared paper)Jing Jin (4 shared papers)Kejia Hu (2 shared papers)Yongzhao Zhou (2 shared papers)Dan Liu (3 shared papers)Yi Huang (1 shared paper)
- Journals
- PLoS ONE (4 papers)Sensors and Actuators B Chemical (2 papers)BMC Cancer (2 papers)Frontiers in Oncology (2 papers)CHEST Journal (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Weimin Li
28 papers receiving 566 citations
Peers
Comparison fields: 5 of 83
- Geriatrics and Gerontology 88
- Oncology 244
- Physiology 190
- Pulmonary and Respiratory Medicine 220
- Cancer Research 58
Countries citing papers authored by Weimin Li
This map shows the geographic impact of Weimin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Li more than expected).
Fields of papers citing papers by Weimin Li
This network shows the impact of papers produced by Weimin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Li. The network helps show where Weimin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Weimin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 175 | |
| 2 | 2017 | 53 | |
| 3 | 2017 | 48 | |
| 4 | 2019 | 38 | |
| 5 | 2014 | 29 | |
| 6 | Gallstone recurrence after successful percutaneous cholecystolithotomy: a 10-year follow-up of 439 cases. | 2007 | 28 |
| 7 | 2022 | 20 | |
| 8 | 2022 | 17 | |
| 9 | 2018 | 16 | |
| 10 | 2015 | 16 | |
| 11 | 2017 | 16 | |
| 12 | 2019 | 15 | |
| 13 | 2024 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2022 | 12 | |
| 16 | [The Research Advancement and Conception of the Deep-underground Medicine]. | 2018 | 10 |
| 17 | 2021 | 9 | |
| 18 | 2025 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2024 | 7 |
About Weimin Li
Weimin Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Physiology and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 572 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (10 papers), Pleural and Pulmonary Diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Lung Cancer Research Studies (4 papers), COVID-19 diagnosis using AI (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Geriatrics and Gerontology (88 citations), Oncology (244 citations), Physiology (190 citations), Pulmonary and Respiratory Medicine (220 citations) and Cancer Research (58 citations). Weimin Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yanjiao Shen, Lingling Tan, Ming Yang, Jing Jin, Kejia Hu, Yongzhao Zhou, Dan Liu, Yi Huang, Juan Song and Lei Li. Their work appears in journals such as PLoS ONE, Sensors and Actuators B Chemical, BMC Cancer, Frontiers in Oncology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.